Pasadena Private Wealth LLC Has $333,000 Position in UnitedHealth Group Incorporated $UNH

Pasadena Private Wealth LLC increased its position in UnitedHealth Group Incorporated (NYSE:UNH) by 16.3% during the second quarter, according to its most recent Form 13F filing with the SEC. The fund owned 1,068 shares of the healthcare conglomerate’s stock after buying an additional 150 shares during the period. Pasadena Private Wealth LLC’s holdings in UnitedHealth Group were worth $333,000 at the end of the most recent reporting period.

A number of other hedge funds have also recently added to or reduced their stakes in the company. Banco Santander S.A. increased its holdings in UnitedHealth Group by 63.5% in the second quarter. Banco Santander S.A. now owns 84,937 shares of the healthcare conglomerate’s stock worth $26,498,000 after buying an additional 32,981 shares during the last quarter. OVERSEA CHINESE BANKING Corp Ltd boosted its position in UnitedHealth Group by 15.3% during the second quarter. OVERSEA CHINESE BANKING Corp Ltd now owns 52,573 shares of the healthcare conglomerate’s stock worth $16,374,000 after purchasing an additional 6,969 shares during the period. Delta Investment Management LLC boosted its position in UnitedHealth Group by 298.1% during the second quarter. Delta Investment Management LLC now owns 27,002 shares of the healthcare conglomerate’s stock worth $8,424,000 after purchasing an additional 20,220 shares during the period. New Hampshire Trust boosted its position in UnitedHealth Group by 14.1% during the second quarter. New Hampshire Trust now owns 937 shares of the healthcare conglomerate’s stock worth $292,000 after purchasing an additional 116 shares during the period. Finally, Prudent Man Advisors LLC boosted its position in UnitedHealth Group by 34.2% during the second quarter. Prudent Man Advisors LLC now owns 3,659 shares of the healthcare conglomerate’s stock worth $1,141,000 after purchasing an additional 932 shares during the period. Institutional investors and hedge funds own 87.86% of the company’s stock.

UnitedHealth Group Stock Performance

Shares of NYSE UNH opened at $362.78 on Monday. The business has a fifty day simple moving average of $338.43 and a 200 day simple moving average of $335.78. The company has a current ratio of 0.85, a quick ratio of 0.85 and a debt-to-equity ratio of 0.73. The firm has a market capitalization of $328.56 billion, a price-to-earnings ratio of 15.72, a PEG ratio of 2.34 and a beta of 0.47. UnitedHealth Group Incorporated has a one year low of $234.60 and a one year high of $630.73.

UnitedHealth Group (NYSE:UNH) last issued its earnings results on Tuesday, July 29th. The healthcare conglomerate reported $4.08 EPS for the quarter, missing analysts’ consensus estimates of $4.45 by ($0.37). The firm had revenue of $111.62 billion during the quarter, compared to analyst estimates of $111.75 billion. UnitedHealth Group had a net margin of 5.04% and a return on equity of 23.32%. The business’s revenue for the quarter was up 12.9% compared to the same quarter last year. During the same quarter in the previous year, the company posted $6.80 earnings per share. UnitedHealth Group has set its FY 2025 guidance at 16.000- EPS. Sell-side analysts expect that UnitedHealth Group Incorporated will post 29.54 EPS for the current year.

UnitedHealth Group Announces Dividend

The business also recently disclosed a quarterly dividend, which was paid on Tuesday, September 23rd. Shareholders of record on Monday, September 15th were paid a dividend of $2.21 per share. This represents a $8.84 annualized dividend and a yield of 2.4%. The ex-dividend date was Monday, September 15th. UnitedHealth Group’s dividend payout ratio is currently 38.30%.

Analyst Upgrades and Downgrades

A number of equities research analysts have issued reports on UNH shares. KeyCorp upped their target price on UnitedHealth Group from $350.00 to $400.00 and gave the stock an “overweight” rating in a research report on Wednesday, October 8th. Morgan Stanley increased their price objective on UnitedHealth Group from $325.00 to $395.00 and gave the company an “overweight” rating in a research report on Friday, September 12th. Weiss Ratings raised UnitedHealth Group from a “sell (d+)” rating to a “hold (c-)” rating in a research report on Friday. Mizuho increased their price objective on UnitedHealth Group from $300.00 to $430.00 and gave the company an “outperform” rating in a research report on Thursday, October 9th. Finally, Zacks Research raised UnitedHealth Group from a “strong sell” rating to a “hold” rating in a research report on Monday, October 6th. Eighteen equities research analysts have rated the stock with a Buy rating, eight have assigned a Hold rating and three have given a Sell rating to the company’s stock. According to data from MarketBeat, UnitedHealth Group currently has an average rating of “Moderate Buy” and a consensus price target of $385.13.

UnitedHealth Group Profile

UnitedHealth Group Incorporated operates as a diversified health care company in the United States. The company operates through four segments: UnitedHealthcare, Optum Health, Optum Insight, and Optum Rx. The UnitedHealthcare segment offers consumer-oriented health benefit plans and services for national employers, public sector employers, mid-sized employers, small businesses, and individuals; health care coverage, and health and well-being services to individuals age 50 and older addressing their needs; Medicaid plans, children's health insurance and health care programs; and health and dental benefits, and hospital and clinical services, as well as health care benefits products and services to state programs caring for the economically disadvantaged, medically underserved, and those without the benefit of employer-funded health care coverage.